Abstract:Background: In this study, we aimed to develop a new end-to-end learning model called Graph-Drug-Target Interaction (DTI), which integrates various types of information in the heterogeneous network data, and to explore automatic learning of the topology-maintaining representations of drugs and targets, thereby effectively contributing to the prediction of DTI. Precise predictions of DTI can guide drug discovery and development. Most machine learning algorithms integrate multiple data sources and combine them with common embedding methods. However, the relationship between the drugs and target proteins is not well reported. Although some existing studies have used heterogeneous network graphs for DTI prediction, there are many limitations in the neighborhood information between the nodes in the heterogeneous network graphs. We studied the drug-drug interaction (DDI) and DTI from DrugBank Version 3.0, protein-protein interaction (PPI) from the human protein reference database Release 9, drug structure similarity from Morgan fingerprints of radius 2 and calculated by RDKit, and protein sequence similarity from Smith-Waterman score. Methods: Our study consists of three major components. First, various drugs and target proteins were integrated, and a heterogeneous network was established based on a series of data sets. Second, the graph neural networks-inspired graph auto-encoding method was used to extract high-order structural information from the heterogeneous networks, thereby revealing the description of nodes (drugs and proteins) and their topological neighbors. Finally, potential DTI prediction was made, and the obtained samples were sent to the classifier for secondary classification. Results: The performance of Graph-DTI and all baseline methods was evaluated using the sums of the area under the precision-recall curve (AUPR) and the area under the receiver operating characteristic curve (AUC). The results indicated that Graph-DTI outperformed the baseline methods in both performance results. Conclusion: Compared with other baseline DTI prediction methods, the results showed that Graph-DTI had better prediction performance. Additionally, in this study, we effectively classified drugs corresponding to different targets and vice versa. The above findings showed that Graph-DTI provided a powerful tool for drug research, development, and repositioning. Graph- DTI can serve as a drug development and repositioning tool more effectively than previous studies that did not use heterogeneous network graph embedding.

NGCN : Drug‐target interaction prediction by integrating information and feature learning from heterogeneous network

Predicting drug–protein interactions by preserving the graph information of multi source data

Drug-Target Prediction Based on Dynamic Heterogeneous Graph Convolutional Network

Graph-DTI: A New Model for Drug-target Interaction Prediction Based on Heterogenous Network Graph Embedding

Drug-Target Interaction Prediction Based on Graph Neural Network and Recommendation System

Metapath-aggregated heterogeneous graph neural network for drug-target interaction prediction

SMGCN: Multiple Similarity and Multiple Kernel Fusion Based Graph Convolutional Neural Network for Drug-Target Interactions Prediction.

A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information

Integrating multi-scale neighbouring topologies and cross-modal similarities for drug–protein interaction prediction

A Biological Feature and Heterogeneous Network Representation Learning-Based Framework for Drug–Target Interaction Prediction

BiTGNN: Prediction of drug–target interactions based on bidirectional transformer and graph neural network on heterogeneous graph

Drug-Target Interactions Prediction Based on Signed Heterogeneous Graph Neural Networks

A Heterogeneous Network-based Contrastive Learning Approach for Predicting Drug-Target Interaction

An End-to-end Heterogeneous Graph Representation Learning-Based Framework for Drug-Target Interaction Prediction.

iGRLDTI: An Improved Graph Representation Learning Method for Predicting Drug-Target Interactions over Heterogeneous Biological Information Network

CSDTI: an interpretable cross-attention network with GNN-based drug molecule aggregation for drug-target interaction prediction

LDS-CNN: a deep learning framework for drug-target interactions prediction based on large-scale drug screening

AMGDTI: drug–target interaction prediction based on adaptive meta-graph learning in heterogeneous network

GPCNDTA: Prediction of drug-target binding affinity through cross-attention networks augmented with graph features and pharmacophores

MGNDTI: A Drug-Target Interaction Prediction Framework Based on Multimodal Representation Learning and the Gating Mechanism

DTI-HeNE: a novel method for drug-target interaction prediction based on heterogeneous network embedding